EU Regulators Warn of Counterfeit Copies of Cancer Drug Herceptin
EU regulators have issued a warning that several batches of the cancer medicine Herceptin (trastuzumab) have been “tampered with,” falsified and reintroduced into the supply chain, potentially putting patients at risk.
High-cost cancer medications like Herceptin have become an increasingly tempting target for thieves and counterfeiters in recent years. While they lack the ready market that some drugs like Viagra have, their extraordinary cost means extraordinary paydays. US officials warned of a similar scare in February 2012, when counterfeit copies of Roche’s Avastin (bevacizumab) were found to have infiltrated the US supply chain. Another batch of the counterfeit drug was found in April 2012.
In the wake of those findings, FDA went after more than a dozen physicians, who were blamed for purchasing the Avastin from unauthorized suppliers in the pursuit of higher profit margins.
Related Posts
Prison guard accused in tobacco smuggling, bribery scheme
A prison guard was indicted on bribery charges Wednesday for allegedly smuggling...
Fake mineral water floods city market
With summer round the corner, it's soon going to be business time for the water...
Cisco sees need to clamp down on counterfeit products
Counterfeit IT products and software are causing a great concern to the industry...
ASPA seeks mandatory authentication, anti-counterfeiting laws
With counterfeiting activities growing at the rate of 44 per cent, authentication...

